The AMR Accelerator programme comprises 9 projects and has 98 participants operating in 18 countries.

Organisations such as universities, research institutes, EFPIA companies, and small and mid-sized companies across Europe, and beyond, collaborate in public-private partnerships, unified by a common goal of developing new tools and therapeutics to fight resistant pathogens, with a particular focus on targeting tuberculosis (TB) and Gram-negative infections.


Antimicrobial resistance knows no boundaries – neither should we!


Click on the map below to find out more about AMR Accelerator partners:
Disclaimer: This map is for graphical purposes only.  The presentation of data on this map does not represent any legal or political reference.  While every effort has been made to ensure that these data are reliable and accurate within the limits of the current state of the art, COMBINE does not assume liability for any omissions or inaccuracies in the data, nor as a result of the failure of the data to function on a particular system. 

Organisation

AMR Accelerator project(s)

Ares Genetics GmbH PrIMAVeRa
Asclepia Outsourcing Solutions COMBINE
BEAM Alliance COMBINE
Bill & Melinda Gates Foundation ERA4TB
BIOASTER GNA NOW & ERA4TB
BIOCOM AG COMBINE
BioVersys Tric-TB
Centre Hospitalier Régional Universitaire de Tours AB-Direct
Centre Hospitalier Universitaire de Poitiers AB-Direct
Clinical Studies Sweden Forum South ERA4TB
Consiglio Nazionale delle Richerche ERA4TB
Critical Path Institute  ERA4TB & UNITE4TB
Danmarks Tekniske Universitet PrIMAVeRa
Deutsches Zentrum Fur Infektionsforschung eV UNITE4TB
Eberhard Karls Universität Tübingen PrIMAVeRa
École polytechnique fédérale de Lausanne ERA4TB
Erasmus MC – University Medical Center Rotterdam GNA NOW
European Lung Foundation UNITE4TB
European Respiratory Society UNITE4TB
European Vaccine Initiative PrIMAVeRa
Evotec ERA4TB, COMBINE & GNA NOW
FFUND BV Respiri-TB & Respiri-NTM
Foundation For Innovative New Diagnostics UNITE4TB
Foundation Innovative Medicines for Tuberculosis ERA4TB
Fraunhofer IME COMBINE & GNA NOW
GlaxoSmithKline Biologicals SA PrIMAVeRa
Glaxosmithkline Investigación Y Desarrollo SL Tric-TB & UNITE4TB
Glaxosmithkline Research And Development LTD ERA4TB, COMBINE & AB-Direct
grit42 COMBINE & ERA4TB
Helmholtz Centre for Infection Research GNA NOW
Helmholtz Institute for Pharmaceutical Research Saarland GNA NOW
Helmholtz Zentrum München UNITE4TB
Hospital of Lithuanian University of Health Sciences Kauno Klinikos PrIMAVeRa
ImaBiotech ERA4TB
Infectious Diseases Models for Innovative Therapies ERA4TB
Inserm GNA NOW & AB-Direct
Institute Pasteur ERA4TB
Institut de Recherche pour le Développement, France UNITE4TB
Institute of Health Carlos III PrIMAVeRa
Institute Pasteur PrIMAVeRa
Institute Pasteur de Lille Foundation ERA4TB
Instituto de Investigación Hospital Universitario La Paz ERA4TB
Instituto De Saude Publica Da Universidade Do Porto UNITE4TB
Janssen Pharmaceutica COMBINE, Respiri-TB, Respiri-NTM, ERA4TB & UNITE4TB
Janssen Vaccines & Prevention B.V. PrIMAVeRa
KNCV Tuberculosis Foundation UNITE4TB
Lancaster University UNITE4TB
Latvian Institute of Organic Synthesis ERA4TB
Leiden University Medical Center Respiri-TB and Respiri-NTM
Life Science Network GmbH PrIMAVeRa
LMU University Hospital Munich UNITE4TB
London School Of Hygiene And Tropical Medicine UNITE4TB
Lygature GNA NOW & UNITE4TB
Medical University of Vienna GNA NOW, AB-Direct, Respiri-TB & Respiri-NTM
Mitologics Respiri-TB & Respiri-NTM
North Bristol NHS Trust GNA NOW
Nosopharm GNA NOW
Otsuka Novel Products GmbH UNITE4TB
Pasteur Institute of Russia PrIMAVeRa
Paul-Ehrlicht-Institut COMBINE
Pfizer PrIMAVeRa
Public Health England ERA4TB
QPS Netherlands ERA4TB
Research Center Borstel ERA4TB & UNITE4TB
Sciensano ERA4TB
Servicio Andaluz de Salud PrIMAVeRa
Sorbonne University Respiri-TB & Respiri-NTM
Statens Serum Institut COMBINE
Stichting Radboud Universitair Medisch Centrum UNITE4TB
Synapse Management Partners ERA4TB
TASK UNITE4TB
TB Alliance ERA4TB & UNITE4TB
Tbnet UNITE4TB
The National Institute for Health and Care Excellence ERA4TB
Université Grenoble Alpes PrIMAVeRa
University Carlos III Madrid ERA4TB
University College London UNITE4TB
University Leiden Respiri-TB & Respiri-NTM
University Medical Center Utrecht PrIMAVeRa
University of Antwerp Respiri-TB & Respiri-NTM
University of California San Francisco UNITE4TB
University of Copenhagen Respiri-TB & Respiri-NTM
University of Dundee ERA4TB
University of Geneva PrIMAVeRa
University of Hamburg UNITE4TB
University of Köln ERA4TB
University of Liverpool GNA NOW
University of Milan UNITE4TB
University of Oxford UNITE4TB & PrIMAVeRa
University of Padova ERA4TB
University of Pavia ERA4TB
University of Poititers GNA NOW & AB-Direct
University of St Andrews UNITE4TB
University of Verona PrIMAVeRa
University of Zaragoza ERA4TB
Uppsala University COMBINE, ERA4TB & UNITE4TB
Vita-Salute San Raffaele University UNITE4TB